Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

NCT03443024

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clear Dermatology & Aesthetics Center Scottsdale, Arizona, United States
  • Dermatology Trial Associates Bryant, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
View all 58 locations
View Trial Details
Completed

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

NCT02563067

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site San Jose, California, United States
  • Novartis Investigative Site Stockton, California, United States
  • Novartis Investigative Site Colorado Springs, Colorado, United States
View all 163 locations
View Trial Details
Completed

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

NCT03568136

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
Locations
  • Klinische Forschung Dresden GmbH Dresden, Germany
  • Carl Gustav Carus University Hospital, Department of Dermatology Dresden, Germany
  • SRH Wald-Klinikum Gera, Center for Clinical Studies Gera, Germany
  • Hannover Medical School, Department for Dermatology, Allergy and Venereology Hanover, Germany
View Trial Details
Completed

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

NCT04339985

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • UNION therapeutics Investigational Site 5 Pleven, Bulgaria
  • UNION therapeutics Investigational Site 2 Sofia, Bulgaria
  • UNION therapeutics Investigational Site 3 Sofia, Bulgaria
  • UNION therapeutics Investigational Site 4 Sofia, Bulgaria
View Trial Details

Related conditions